| Literature DB >> 36136697 |
Vito Priolo1, Pamela Martínez-Orellana2, Maria Grazia Pennisi1, Ana Isabel Raya-Bermúdez3, Estefania Jurado-Tarifa3, Marisa Masucci1, Giulia Donato1, Federica Bruno4, Germano Castelli4, Laia Solano-Gallego2.
Abstract
Dogs are the main reservoir of Leishmania infantum and display different immunological patterns correlating with the progression of infection to disease. Data about feline L. infantum adaptive immune response are scant. This study aimed to compare the prevalence and immune response in cats and dogs from the same endemic area of canine leishmaniosis. Stray cats (109) and rescued dogs (59) from Córdoba (Spain) were enrolled. Data about their exposure to L. infantum were analyzed by detection of parasite DNA, measurements of Leishmania-specific interferon-γ (whole blood assay in 57 cats and 29 dogs), and antibodies (enzyme-linked immunosorbent assay and immunofluorescence antibody test). An overall L. infantum prevalence of 30.5% in dogs and 30% in cats were found according to serology and PCR tests. Prevalence was 44.8% in dogs and 35.1% in cats tested also for interferon-γ production. Dogs showed higher anti-L. infantum antibody levels compared to cats. More than one-third of cats had contact with or were infected by L. infantum and they may contribute to the endemicity of leishmaniosis in the investigated region. The immunopathogenesis of feline L. infantum infection has similarities with dogs but cats show a lower level of adaptive immune response compared to dogs.Entities:
Keywords: ELISA; IFAT; IFN-γ; PCR; canine; feline; feline immunodeficiency virus; leishmaniosis; prevalence; whole blood assay
Year: 2022 PMID: 36136697 PMCID: PMC9505219 DOI: 10.3390/vetsci9090482
Source DB: PubMed Journal: Vet Sci ISSN: 2306-7381
Demographic data of enrolled animals and p values for significant differences between dogs and cats.
| Variable | Cat N (%) Dog N (%) |
| OR | 95% CI | |
|---|---|---|---|---|---|
| Sex * | 0.0466 | 2.018 | 1.044–3.765 | ||
| Female | 63 (57.8) | 27 (45.8) | |||
| Male | 37 (34) | 32 (54.2) | |||
| Unreported | 9 (8.2) | 0 | |||
| Age class * | 0.0053 | 4.474 | 1.515–12.39 | ||
| Young | 26 (23.8) | 4 (6.8) | |||
| Adult and old | 77 (70.6) | 53 (89.8) | |||
| Unknown | 6 (5.5) | 2 (3.4) | |||
| Breed | na | na | na | ||
| Cat | |||||
| DSH | 109 | na | |||
| Dog | |||||
| Crossbreed | na | 20 (33.9) | |||
| AWCRHD | na | 1 (1.7) | |||
| JRT | na | 1 (1.7) | |||
| Greyhound | na | 32 (54.2) | |||
| German shepherd | na | 1 (1.7) | |||
| Podenco | na | 2 (3.4) | |||
| Shar-pei | na | 1 (1.7) | |||
| Pointer | na | 1 (1.7) | |||
DSH = Domestic Shorthair; AWCRHD = Andalusian Wine-Cellar Rat-Hunting Dog; JRT = Jack Russell terrier; na = not applicable; * = significant difference; 95% CI = 95% confidence interval; OR = odds ratio.
Number and percentage values of dogs and cats positive to different diagnostic tests for L. infantum, median, 25th and 75th percentiles and range of results for different tests.
| Test and Species | N (%) | Median | 25th–75th Percentile | Range |
| OR | 95% CI | |
|---|---|---|---|---|---|---|---|---|
| MWT | FET | |||||||
| ELISA and/or IFAT | na | ns | na | na | ||||
| Cats | 26/107 (24.3) | na | na | na | ||||
| Dogs | 16/59 (27.1) | na | na | na | ||||
| ELISA (EU) * | 0.0035 | 0.0020 | 7.075 | 1.907–24.53 | ||||
| Cats | 3/107 (2.8) | 14.75 | 13.69–19.57 | 13.69–19.57 | ||||
| Dogs | 10/59 (17) | 297.9 | 40.43–400 | 36.51–400 | ||||
| IFAT (Titer) * | <0.0001 | |||||||
| Cats | 24/109 (22) | 1:80 | 1:80–1:160 | 1:80–1:320 | ||||
| Dogs | 16/59 (27.1) | 1:640 | 1:160–1:5120 | 1:160–1:10,280 | ||||
| PCR (am/mL) | ||||||||
| Cats | 9/109 (8.3) | 60 | 47.5–72.5 | 30–75 | ||||
| Dogs | 7/59 (11.9) | 82 | 10–250 | 5–440 | ||||
| LSA-IFN-γ (pg/mL) | ||||||||
| Cats § | 9/57 (15.8) | 45.5 | 40.1–79.5 | 33.5–172.3 | ||||
| Dogs # | 6/29 (20.7) | 176.2 | 72.2–2465.1 | 70.6–3241 | ||||
| ConA-IFN-γ (pg/mL) | ||||||||
| Cats § | 55/57 (96.5) | 1531.5 | 203.6–4295 | 35.1–9492.6 | ||||
| Dogs # | 28/29 (96.5) | 2048.5 | 593.8–2534 | 69.5–5319 | ||||
| Overall positivity | ||||||||
| Cats | 32/107 (30) ^ | |||||||
| 20/57 (35.1) ~ | na | na | na | |||||
| Dogs | 18/59 (30.5) ^ | |||||||
| 13/29 (44.8) ~ | na | na | na | |||||
ELISA = enzyme-linked immunosorbent assay; IFAT = immunofluorescence antibody test; EU = ELISA unit; PCR = polymerase chain reaction; LSA-IFN-γ = L. infantum specific interferon-γ concentration; na = not applicable; FET = Fisher’s Exact test; MWT = Mann Whitney’s test; * = significant difference; OR = odds ratio; 95% CI = 95% confidence interval; ^ = overall positivity including individuals positive to at least one of the following tests: IFAT and/or ELISA and/or PCR; ~ = overall positivity including individuals positive to at least one of the following tests: IFAT and/or ELISA and/or PCR and/or LSA-IFN- γ; am = amastigotes. # = the levels of ConA-IFN-γ were statistically higher compared to those obtained after LSA stimulation in dogs (p < 0.0001, ConA-IFN-γ median: 1515 pg/mL, range: 35.6-5319 pg/mL, 25th–75th percentile: 476.4-2651 pg/mL, LSA-IFN-γ median: 20.39 pg/mL, range: 0–3241 pg/mL, 25th–75th percentile: 1.5–68.33 pg/mL). § = the levels of ConA-IFN-γ were statistically higher compared to those obtained after LSA stimulation in cats (p < 0.0001, ConA-IFN-γ median: 951 pg/mL, range: 0–9493 pg/mL, 25th 75th percentile: 140.5–3378 pg/mL, LSA-IFN-γ median: 0 pg/mL, range: 0–172.3 pg/mL, 25th–75th percentile: 0–13.06 pg/mL).
Description of the number of IFN-γ producer and not producer dogs and cats positive at IFAT, ELISA, IFAT + ELISA or PCR with description of the IFAT titers and ELISA units (EU).
| LSA-IFN-γ | IFAT (N, Titer) | ELISA | IFAT + ELISA | PCR |
|---|---|---|---|---|
| Producer dogs: 6 | 1 (1:160) | 0 | 0 | 0 |
| Producer cats: 9 | 3 (1:80) | 1 (19.6 EU) | 0 | 0 |
| Not producer dogs: 23 | 5 (1:160–1:10,280) | 3 (41.3–400 EU) | 3 | 4 |
| Not producer cats: 48 | 8 (1:80–1:320) | 0 | 0 | 3 |
Studies evaluating Leishmania infantum antibody and PCR prevalences in cats from European endemic areas.
| Reference | Country (Region or City) | Lifestyle | Number of Cats Studied | Percentage of Positivity to | |||
|---|---|---|---|---|---|---|---|
| IFAT (Cut off) | ELISA | Western Blot (Serum Dilution) | PCR (Tissue) | ||||
| Alcover et al., 2021 [ | Spain | Stray | 180 | 2.2 (1:20) | 2.8% (1:200) | 14.5 (1:200) | 5.6 (blood) |
| Miró et al., 2014 [ | Spain | Stray | 346 | 3.2 (1:100) | n.p. | n.p. | 0 (blood) |
| Montoya et al., 2018 [ | Spain | Stray | 632 | 4.8 (1:100) | n.p | n.p. | 0 (blood) |
| Millán et al., 2011 [ | Spain | Stray | 86 | n.p | n.p. | 16 (1:10) | 26 (blood and/or spleen) |
| Spada et al., 2013 [ | Italy | Stray | 233 | 25.3 (1:40) | n.p. | n.p. | 0 (blood) |
| Spada et al., 2016 [ | Italy | Stray | 90 | 30 (1:40) | n.p. | n.p. | 1.1 (blood) |
| Spada et al., 2020 [ | Italy | Stray | 117 | 4.9 (1:80) | n.p. | n.p. | 0 (blood) |
| Morganti et al., 2019 [ | Italy | Cattery and colony cats | 286 | 10.8 (1:40) | n.p | n.p. | 0% (blood) |
| Duarte et al., 2010 [ | Portugal | Stray | 231 | 0.6 (1:40) | n.p. | n.p. | n.p. |
| Maia et al., 2014 [ | Portugal | Stray | 329 | n.p. | n.p | n.p. | 8.6 (blood) |
| Diakou et al., 2009 [ | Greece | Stray | 284 | n.p. | 3.87% (n.a.) | n.p. | n.p. |
| Diakou et al., 2017 [ | Greece | Stray and free-roaming | 148 | 6.1 (1:80) | n.p. | n.p. | 6.1 (blood) |
n.p.: not performed; n.a.: not available.